ID: ALA416893

Max Phase: Preclinical

Molecular Formula: C17H18N2

Molecular Weight: 250.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  c1ccc(C(CC2=NCCN2)c2ccccc2)cc1

Standard InChI:  InChI=1S/C17H18N2/c1-3-7-14(8-4-1)16(13-17-18-11-12-19-17)15-9-5-2-6-10-15/h1-10,16H,11-13H2,(H,18,19)

Standard InChI Key:  RATCNRNTKXYAHW-UHFFFAOYSA-N

Associated Targets(Human)

Nischarin 304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Nischarin 241 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 250.35Molecular Weight (Monoisotopic): 250.1470AlogP: 3.21#Rotatable Bonds: 4
Polar Surface Area: 24.39Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.59CX LogP: 3.07CX LogD: 0.72
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.88Np Likeness Score: -0.07

References

1. Baurin N, Vangrevelinghe E, Morin-Allory L, Mérour JY, Renard P, Payard M, Guillaumet G, Marot C..  (2000)  3D-QSAR CoMFA study on imidazolinergic I(2) ligands: a significant model through a combined exploration of structural diversity and methodology.,  43  (6): [PMID:10737743] [10.1021/jm991124t]
2. Nicolotti O, Carotti A, Carrieri A, Pigini M, Gentili F, Brasili L, Giannella M, Quaglia W, Piergentili A, Bousquet P, Dontenwill M.  (2004)  Alpha2-Adrenergic Receptors in Intestinal Epithelial Cells: Mechanisms of Signaling, Role, and Regulation,  13  (3): [10.1007/s00044-004-0023-9]

Source